Hyderabad: Bharat Biotechās Oral Cholera Vaccine HillcholĀ® has demonstrated against both Ogawa and Inaba serotypes, proving non-inferior in healthy Indian adults and children, supporting its potential as an effective OCV. The above findings have been published in the ScienceDirect, Vaccine journal...